Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit AB1 (NDUFAB1)

Target
NDUFAB1
Molecular classification
Enzyme (Complex I subunit), Accessory subunit (Electron transport chain), Acyl carrier protein
01

Overview

NADH:ubiquinone oxidoreductase subunit AB1 (NDUFAB1) is a mitochondrial acyl carrier protein and an accessory, non-catalytic subunit of Complex I (NADH dehydrogenase) in the mitochondrial electron transport chain[1][3][4]. The protein is encoded on chromosome 16p12.2 and consists of 156 amino acids, forming an L-shaped structure with both hydrophobic transmembrane and hydrophilic peripheral arm domains[1][3]. NDUFAB1 is critical in cellular respiration, acting as an anchor for complex I and participating in electron transfer from NADH to ubiquinone[3][4]. Beyond its structural role, it coordinates the assembly and stability of mitochondrial respiratory complexes and supercomplexes by regulating iron-sulfur cluster biosynthesis, contributing to energy production and limiting pathologic ROS emission[2]. It also functions as a carrier for growing fatty acid chains, and participates in iron-sulfur cluster biogenesis, which is essential for the activity of many mitochondrial enzymes[1][5][6]. Cardiac-specific deficiency leads to severe mitochondrial dysfunction, increased ROS, dilated cardiomyopathy, and heart failure in animal models, highlighting its essential role in mitochondrial health and function[2]. It is associated with genetic risk for anxiety disorders and congenital heart defects such as Tetralogy of Fallot[3]. NDUFAB1 is widely conserved and indispensable for cell viability in some cell types[7]. No approved drugs directly target NDUFAB1, but modulation represents a promising therapeutic strategy for mitochondrial diseases and heart failure[2][3].

Other names
Acyl carrier protein, mitochondrialACPACP1SDAPFASN2ACI-SDAPNADH-ubiquinone oxidoreductase 9.6 kDa subunitcomplex I SDAP subunitNADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1mitochondrial acyl carrier protein
02

Mechanism of action

Current evidence suggests therapeutic intervention would act by modulating assembly/function of electron transport chain complexes, enhancing mitochondrial bioenergetics, or limiting ROS production

03

Biological functions

Mitochondrial electron transport chain, Complex I assemblyCarrier of growing fatty acid chains (fatty acid biosynthesis)Coordination of assembly for mitochondrial respiratory complexes (I, II, III) and supercomplexesRegulation of iron-sulfur cluster biogenesisEnergy metabolism and reactive oxygen species (ROS) regulation
04

Disease associations

Cardiovascular disease (protection against heart failure, involvement in cardiomyopathy)Potential neuropsychiatric links (genetic risk locus for anxiety disorders)Congenital heart disease (identified as a hub gene in Tetralogy of Fallot)
05

Safety considerations

Safety concerns would center on disruption of mitochondrial bioenergetics and ROS metabolism, leading to risk of cardiomyopathy, heart failure, and potential systemic cellular dysfunctionNDUFAB1 is essential for cell viability in certain cell types
06

Interacting drugs

No specific drugs known to directly target NDUFAB1 or used clinically at this time
07

Biomarkers

No clinically established biomarkers, but changes in cardiac mitochondrial bioenergetics, ROS levels, and complex I/III/II subunit integrity may serve as experimental markers for NDUFAB1 function or deficiency

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit AB1 (NDUFAB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit AB1 (NDUFAB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call